Dapsone hypersensitivity syndrome in a patient with cutaneous lupus erythematosus.
Christiansen
J
J
Tegner
E
E
Irestedt
M
M
D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D003622:Dapsone / Q000008:administration & dosage / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000175:diagnosis*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced* / Q000188:drug therapy; D008178:Lupus Erythematosus, Cutaneous / Q000175:diagnosis / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage; D013577:Syndrome; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D003622:Dapsone; D011241:Prednisone